Latest & greatest articles for hiv

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on hiv or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on hiv and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for hiv

246. Models to inform fast tracking voluntary medical male circumcision in HIV combination prevention: meeting report, 23–24 March 2016

Models to inform fast tracking voluntary medical male circumcision in HIV combination prevention: meeting report, 23–24 March 2016 WHO IRIS: Models to inform fast tracking voluntary medical male circumcision in HIV combination prevention: meeting report, 23–24 March 2016 Browse Related links Files in This Item: File Description Size Format 668.08 kB Adobe PDF Title: Models to inform fast tracking voluntary medical male circumcision in HIV combination prevention: meeting report, 23–24 March 2016 (...) Authors: Issue Date: 2017 Publisher: World Health Organization Place of publication: Geneva Language: English Description: 28 p. Subject: Context: prevention and control Gov't Doc #: WHO/HIV/2017.39 URI: License: CC BY-NC-SA 3.0 IGO License URL: Appears in Collections: Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated. |

WHO2017

247. HIV drug resistance report 2017

HIV drug resistance report 2017 WHO IRIS: Log In Sign on to: Browse My repository Sign on to: Related links Log In to WHO IRIS Please enter your e-mail address and password into the form below. E-mail Address: Password: |

WHO2017

248. WHO implementation tool for pre-exposure prophylaxis (PrEP) of HIV infection: module 1: clinical

WHO implementation tool for pre-exposure prophylaxis (PrEP) of HIV infection: module 1: clinical WHO IRIS: Log In Sign on to: Browse My repository Sign on to: Related links Log In to WHO IRIS Please enter your e-mail address and password into the form below. E-mail Address: Password: |

WHO2017

249. WHO implementation tool for pre-exposure prophylaxis (PrEP) of HIV infection

WHO implementation tool for pre-exposure prophylaxis (PrEP) of HIV infection WHO IRIS: Log In Sign on to: Browse My repository Sign on to: Related links Log In to WHO IRIS Please enter your e-mail address and password into the form below. E-mail Address: Password: |

WHO2017

250. HIV treatment and care: what's new in treatment monitoring: viral load and CD4 testing: information note

HIV treatment and care: what's new in treatment monitoring: viral load and CD4 testing: information note WHO IRIS: Log In Sign on to: Browse My repository Sign on to: Related links Log In to WHO IRIS Please enter your e-mail address and password into the form below. E-mail Address: Password: |

WHO2017

251. HIV treatment: transition to new antiretrovirals in HIV programmes: policy brief

HIV treatment: transition to new antiretrovirals in HIV programmes: policy brief WHO IRIS: Log In Sign on to: Browse My repository Sign on to: Related links Log In to WHO IRIS Please enter your e-mail address and password into the form below. E-mail Address: Password: |

WHO2017

252. The future of HIV services in England

The future of HIV services in England The future of HIV services in England | The King's Fund Search form Search The future of HIV services in England Shaping the response to changing needs 25 April 2017 , , , , This report explores the challenges and opportunities facing HIV services in four areas in England, and makes recommendations on future development to those in national and local leadership roles. Print copy: £10 | No. of pages: 98 ISBN: 978 1 909029 73 6 Overview Care for people (...) with HIV is now highly effective, and increasing numbers of people are living with HIV into older age with normal life expectancy. For example, in London there are now around four times as many people over the age of 50 living with HIV as there were 10 years ago. HIV services need to adapt to this changing demographic, co-ordinating more closely with the other health and care services that older people need and focusing on overall quality of life as well as clinical treatment. Health reforms in 2012

The King's Fund2017

253. HIV patient monitoring and case surveillance: what's new in person-centred HIV patient monitoring and case surveillance: technical brief

HIV patient monitoring and case surveillance: what's new in person-centred HIV patient monitoring and case surveillance: technical brief WHO IRIS: HIV patient monitoring and case surveillance: what's new in person-centred HIV patient monitoring and case surveillance: technical brief Browse Related links Files in This Item: File Description Size Format 183.43 kB Adobe PDF Title: HIV patient monitoring and case surveillance: what's new in person-centred HIV patient monitoring and case (...) surveillance: technical brief Authors: Issue Date: 2017 Publisher: World Health Organization Place of publication: Geneva Language: English Description: 4 p. Subject: Gov't Doc #: WHO/HIV/2017.11 URI: License: CC BY-NC-SA 3.0 IGO License URL: Appears in Collections: Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated. |

WHO2017

254. HIV-Positive Women Taking Lifelong Antiretroviral Therapy Report Better Adherence Than Women Taking Short-Course Prophylaxis During and After Pregnancy Under PMTCT Program Option A in Lusaka, Zambia

HIV-Positive Women Taking Lifelong Antiretroviral Therapy Report Better Adherence Than Women Taking Short-Course Prophylaxis During and After Pregnancy Under PMTCT Program Option A in Lusaka, Zambia 28798891 2018 11 13 2161-8674 6 1 2017 International journal of MCH and AIDS Int J MCH AIDS HIV-Positive Women Taking Lifelong Antiretroviral Therapy Report Better Adherence Than Women Taking Short-Course Prophylaxis During and After Pregnancy Under PMTCT Program Option A in Lusaka, Zambia. 27-35 (...) 10.21106/ijma.164 HIV-positive women's adherence to antiretrovirals is critical for prevention of mother-to-child transmission. We aimed to establish if mothers taking triple lifelong antiretroviral therapy report higher adherence compared to mothers taking short-course prophylaxis under Option A in Lusaka, Zambia. In this clinic-based cross-sectional study, we interviewed 320 HIV-positive mothers at a large public health facility in Lusaka in 2014. Participants reported adherence using a visual analog

International journal of MCH and AIDS2017 Full Text: Link to full Text with Trip Pro

255. A Novel Combined Mother-Infant Clinic to Optimize Post-Partum Maternal Retention, Service Utilization, and Linkage to Services in HIV Care in Rural Rwanda

A Novel Combined Mother-Infant Clinic to Optimize Post-Partum Maternal Retention, Service Utilization, and Linkage to Services in HIV Care in Rural Rwanda 28798892 2018 11 13 2161-8674 6 1 2017 International journal of MCH and AIDS Int J MCH AIDS A Novel Combined Mother-Infant Clinic to Optimize Post-Partum Maternal Retention, Service Utilization, and Linkage to Services in HIV Care in Rural Rwanda. 36-45 10.21106/ijma.186 Despite recent improvements in accessibility of services to prevent (...) mother-to-child transmission of HIV, maternal retention in HIV care remains a challenge in the post-partum period. This study assessed service utilization, program retention, and linkage to routine services, as well as clinical outcomes for mothers and infants, following implementation of an integrated mother-infant clinic in rural Rwanda. We conducted a retrospective cohort study of all HIV-positive mothers and their infants enrolled in the integrated clinics in two rural districts between July 1

International journal of MCH and AIDS2017 Full Text: Link to full Text with Trip Pro

256. Pregnancy Outcomes in HIV-Infected Women: Experience from a Tertiary Care Center in India

Pregnancy Outcomes in HIV-Infected Women: Experience from a Tertiary Care Center in India 28798896 2018 11 13 2161-8674 6 1 2017 International journal of MCH and AIDS Int J MCH AIDS Pregnancy Outcomes in HIV-Infected Women: Experience from a Tertiary Care Center in India. 75-81 10.21106/ijma.196 There is conflicting data on the effect of HIV infection as well as antiretroviral therapy (ART) on pregnancy outcome. The objectives of this study were to compare pregnancy outcomes in women (...) with and without HIV infection, and to evaluate the effect of HAART on pregnancy in HIV-infected women. This is a prospective case record analysis of 212 HIV-infected women delivering between 2002 and 2015, in a tertiary health care center in India. The pregnancy outcome in HIV-infected women was compared to 238 HIV-uninfected controls. Women received ART for prevention of mother to child transmission as per protocol which varied during the period of study. Effect of use of ART on preterm birth (PTB

International journal of MCH and AIDS2017 Full Text: Link to full Text with Trip Pro

257. Determinants of Voluntary HIV/AIDS Counseling and Testing among Community College Students in the United States

Determinants of Voluntary HIV/AIDS Counseling and Testing among Community College Students in the United States 29367887 2018 11 13 2161-8674 6 2 2017 International journal of MCH and AIDS Int J MCH AIDS Determinants of Voluntary HIV/AIDS Counseling and Testing among Community College Students in the United States. 109-120 10.21106/ijma.212 Human Immunodeficiency Virus (HIV) testing remains the best public health preventive strategy in the fight against HIV/AIDS. We assessed the factors (...) that determined voluntary counseling and screening/testing for HIV among college students. In this cross-sectional study, a purposeful sample of 189 college students was analyzed using three health belief model (HBM) variables as the theoretical framework. All the HBM variables were positively associated with intention to test for HIV, and with perceived benefits ( p = 0.023) having the strongest association. The results of this study underscore the important factors that predict intention to screen for HIV

International journal of MCH and AIDS2017 Full Text: Link to full Text with Trip Pro

258. Policy-maker attitudes to the ageing of the HIV cohort in Botswana

Policy-maker attitudes to the ageing of the HIV cohort in Botswana 28922992 2018 07 02 2018 11 13 1813-4424 14 1 2017 12 SAHARA J : journal of Social Aspects of HIV/AIDS Research Alliance SAHARA J Policy-maker attitudes to the ageing of the HIV cohort in Botswana. 31-37 10.1080/17290376.2017.1374879 The roll out of antiretroviral therapy in Botswana, as in many countries with near universal access to treatment, has transformed HIV into a complex yet manageable chronic condition and has led (...) to the emergence of a population aging with HIV. Although there has been some realization of this development at international level, no clear defined intervention strategy has been established in many highly affected countries. Therefore we explored attitudes of policy-makers and service providers towards HIV among older adults (50 years or older) in Botswana. We conducted qualitative face-to-face interviews with 15 consenting personnel from the Ministry of Health, medical practitioners and non-governmental

SAHARA J : journal of Social Aspects of HIV/AIDS Research Alliance2017 Full Text: Link to full Text with Trip Pro

259. Systematic Differences in HIV, Syphilis and Risk Behaviors among Street Based and Establishment Based Female Sex Workers in Kathmandu Valley of Nepal

Systematic Differences in HIV, Syphilis and Risk Behaviors among Street Based and Establishment Based Female Sex Workers in Kathmandu Valley of Nepal 28804674 2018 11 13 2091-0800 6 4 2016 Dec Nepal journal of epidemiology Nepal J Epidemiol Systematic Differences in HIV, Syphilis and Risk Behaviors among Street Based and Establishment Based Female Sex Workers in Kathmandu Valley of Nepal. 620-630 10.3126/nje.v6i4.17256 Female Sex Workers (FSWs) are main drivers of the HIV epidemic in Nepal (...) . The work environment of sex work in Nepal is differentiated into establishment based (e.g. massage parlors, dance restaurants, hotels and lodges) and street based (e.g. streets, parks and markets). The study compares HIV, syphilis and risk behaviours among establishment-based FSWs and street-based FSWs in Kathmandu Valley of Nepal. Cross-sectional bio-behavioral surveys in 2006, 2008, 2011 and 2015 aimed to sample 2093 FSWs using two stage cluster sampling in the Kathmandu valley. Statistical analysis

Nepal journal of epidemiology2016 Full Text: Link to full Text with Trip Pro

260. Lipodystrophy HIV-related and FGF21: A new marker to follow the progression of lipodystrophy?

Lipodystrophy HIV-related and FGF21: A new marker to follow the progression of lipodystrophy? 28191538 2018 11 13 2450-131X 4 4 2016 Dec 01 Journal of translational internal medicine J Transl Int Med Lipodystrophy HIV-related and FGF21: A new marker to follow the progression of lipodystrophy? 150-154 10.1515/jtim-2016-0026 Recently new evidence about fibroblast growth factor 21 (FGF21) highlights the opportunities to use this molecule in new pharmaceutical formulations to combat type 2 diabetes (...) and metabolic syndrome. It is well known that HIV is per se a condition of insulin resistance and in particular the patient with HIV-related lipodystrophy has a condition strictly related to metabolic syndrome. Lipodystrophy is associated with severe metabolic side effects, including dyslipidemia, hepatic insulin resistance, and lipid oxidation impairment. Research carried out showed that FGF21 levels were significantly increased in untreated HIV-1-infected patients and the increase was much

Journal of translational internal medicine2016 Full Text: Link to full Text with Trip Pro